EpiCypher产品代理

产品分类 > 科研试剂 > EpiCypher产品代理

EpiCypher产品代理

EpiCypher 是一家由 Drs 于 2012 年创立的表观遗传学公司。 Mark Bedford、Or Gozani、Brian Strahl 和 James Bone 响应对高质量试剂和工具不断增长的需求,以研究染色质调控并实现以表观遗传学为重点的药物开发EpiCypher 是重组核小体制造和开发的全球领导者。使用专有方法,我们不断增加世界上最大的高纯度修饰重组“设计者”核小体 (dNucs™) 集合。 EpiCypher 广泛的 dNuc™ 多样性为破译组蛋白代码和加速药物开发提供了强大的工具。 Shah 等人、Wang 等人和 Weinberg 等人。 (见下文)只是使用核小体底物进行表观遗传学研究的诸多好处的几个例子。
EpiCypher 利用 dNuc™ 技术进行广泛的应用,包括:SNAP-ChIP® Spike-in Controls(用于抗体分析和定量 ChIP)、EpiDyne® 底物(用于表征染色质重塑酶复合物和抑制剂)和 dCypher™ 分析(用于询问表观遗传蛋白-组蛋白 PTM 结合相互作用)。我们还提供一套高质量的重组组蛋白结合蛋白、酶、肽、抗体和定制化验开发服务,以补充这些平台。
EpiCypher 不断突破技术界限,为表观遗传学和染色质生物学研究人员提供创新产品、解决方案和服务。最近,随着最近推出的用于 ChIC、CUT&RUN 和 CUT&Tag 的高灵敏度表观基因组映射 CUTANA™ 分析,EpiCypher 一直处于染色质映射技术改进的前沿。
从我们强大的科学专业知识和严谨性到我们对客户成功的关注,EpiCypher 很自豪能成为科学家的表观遗传公司,由科学家。
价格: 0.00

EpiCypher is an epigenetics company founded in 2012 by Drs. Mark Bedford, Or Gozani, Brian Strahl, and James Bone in response to the growing demand for high-quality reagents and tools to study chromatin regulation and enable 

epigenetics-focused   drug development.

EpiCypher is   the global leader in recombinant nucleosome manufacturing and development.   Using proprietary methods, we are continuously adding to the world’s largest   collection of highly pure modified recombinant “designer” nucleosomes (dNucs™). EpiCypher’s broad dNuc™ diversity is providing a powerful tool to decipher the histone   code and accelerate drug development. Shah et al., Wang et al., and Weinberg   et al. (see below) are just a few examples of the many benefits of using   nucleosome substrates for epigenetics studies.

EpiCypher   leverages dNuc™ technology for a wide range of applications, including:   SNAP-ChIP® Spike-in Controls (for antibody profiling and quantitative ChIP),   EpiDyne® substrates (for characterizing chromatin remodeling enzyme complexes   and inhibitors), and dCypher™ assays (for interrogation of epigenetic protein-histone PTM   binding interactions). We also offer a suite of high-quality recombinant   histone binding proteins, enzymes, peptides, antibodies, and custom assay   development services to complement these platforms.

   

EpiCypher continuously pushes technology boundaries to deliver innovative products, solutions, and services to epigenetics and chromatin biology researchers. Most recently, EpiCypher has been at the leading edge of chromatin mapping technology improvements with the recent launch of the highly sensitive epigenomic mapping CUTANA™ assays for ChIC, 

CUT&RUN,   and CUT&Tag.

   

From our strong scientific expertise and rigor to our focus on customer success, EpiCypher is proud to be an epigenetics company For Scientists, By Scientists.


上一个: epigendx产品代理
下一个: eolabs产品代理